Efficacy and Safety of Semaglutide Once-weekly Versus Exenatide ER 2.0 mg Once-weekly as add-on to 1-2 Oral Antidiabetic Drugs (OADs) in Subjects With Type 2 Diabetes
Clinical trial NCT01885208 · COMPLETED
Trial details
- NCT number
- NCT01885208
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-02
- Primary completion
- 2015-07-13
- Enrollment
- 813
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.